Burning Rock Biotech Ltd (BNR): R&D Expense

Annual figures by period end, from SEC filings.

166.49M CNY
Year ended 2025-12-31
-26.6%
3-year compound annual growth
-8.8%
5-year compound annual growth
421.87M CNY2018-12-31: 105.30M CNY2019-12-31: 156.94M CNY2020-12-31: 263.94M CNY2021-12-31: 367.86M CNY2022-12-31: 421.87M CNY2023-12-31: 347.02M CNY2024-12-31: 232.29M CNY2025-12-31: 166.49M CNY166.49M CNY
2018-12-31 R&D Expense (CNY) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31166.49M CNY-28.3%2026-04-28, From 2025-01-01
2024-12-31232.29M CNY-33.1%2026-04-28, From 2024-01-01
2023-12-31347.02M CNY-17.7%2026-04-28, From 2023-01-01
2022-12-31421.87M CNY+14.7%2025-04-29, From 2022-01-01
2021-12-31367.86M CNY+39.4%2024-04-29, From 2021-01-01
2020-12-31263.94M CNY+68.2%2023-04-20, From 2020-01-01
2019-12-31156.94M CNY+49.0%2022-04-29, From 2019-01-01
2018-12-31105.30M CNYn/a2021-03-23, From 2018-01-01